Quick Answer
PALISADE BIO, INC. reported Stockholders Equity of $129.38 million for fiscal year 2025.
PALISADE BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $129.38M | +1626.9% |
| 2024 | $7.49M | -33.8% |
| 2023 | $11.31M | -9.3% |
| 2022 | $12.48M | +69.4% |
| 2021 | $7.37M | +144.4% |
| 2020 | -$16.60M | -99.3% |
| 2019 | -$8.33M | -237.7% |
| 2018 | $6.05M | -29.0% |
| 2017 | $8.52M | -24.8% |
| 2016 | $11.33M | +128.1% |
| 2015 | $4.97M | -72.0% |
| 2014 | $17.72M | +110.5% |
| 2013 | $8.42M | +20.7% |
| 2012 | $6.97M | +320.1% |
| 2011 | $1.66M | -78.9% |
| 2010 | $7.85M | +256.6% |
| 2009 | -$5.02M | -96.2% |
| 2008 | -$2.56M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.21M | -51.4% | +22.6% |
| June 30, 2025 | $2.62M | -73.7% | -50.9% |
| March 31, 2025 | $5.33M | -47.0% | -28.8% |
| December 31, 2024 | $7.49M | -33.8% | +13.4% |
| September 30, 2024 | $6.61M | -53.1% | -33.6% |
| June 30, 2024 | $9.95M | -37.0% | -1.1% |
| March 31, 2024 | $10.06M | -26.8% | -11.0% |
| December 31, 2023 | $11.31M | -9.3% | -19.7% |
- PALISADE BIO, INC. showed an increase of +1626.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, PALISADE BIO, INC.’s stockholders equity has grown by 5160.7% (from -$2.56 million to $129.38 million).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: